David will provide an overview of our key business updates, Colleen will provide details on the commercial launch of Atrozy, and Philippe will discuss our financial and operating updates. Now I'll ...
Verley just received a “no-questions” approval letter from the FDA for its two flagship precision fermented dairy proteins ...
Their combined market capitalisation rose 4% from $3.7 trillion on 30 June 2025 to $3.8 trillion on 30 September 2025.
The deal comes after Pfizer on Monday filed a second lawsuit against Metsera and Novo Nordisk, alleging the weight-loss drug ...
Investor's Business Daily on MSN
Sarepta Loses Almost A Third Of Its Value On Failed Tests, Gene Therapy Outlook
Sarepta stock crashed Tuesday after the biotech company said two of its muscular dystrophy drugs failed confirmatory tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback